CN1262625A - 乳铁蛋白在治疗过敏原诱发疾病中的应用 - Google Patents

乳铁蛋白在治疗过敏原诱发疾病中的应用 Download PDF

Info

Publication number
CN1262625A
CN1262625A CN98805584A CN98805584A CN1262625A CN 1262625 A CN1262625 A CN 1262625A CN 98805584 A CN98805584 A CN 98805584A CN 98805584 A CN98805584 A CN 98805584A CN 1262625 A CN1262625 A CN 1262625A
Authority
CN
China
Prior art keywords
lactoferrin
inflammatory disease
tnf
induced
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98805584A
Other languages
English (en)
Chinese (zh)
Inventor
I·金伯
M·坎伯巴奇
R·J·迪尔曼
O·M·康萘利
P·沃德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agennix Inc
Original Assignee
Agennix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agennix Inc filed Critical Agennix Inc
Publication of CN1262625A publication Critical patent/CN1262625A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN98805584A 1997-04-10 1998-04-10 乳铁蛋白在治疗过敏原诱发疾病中的应用 Pending CN1262625A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4189097P 1997-04-10 1997-04-10
US60/041,890 1997-04-10

Publications (1)

Publication Number Publication Date
CN1262625A true CN1262625A (zh) 2000-08-09

Family

ID=21918897

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98805584A Pending CN1262625A (zh) 1997-04-10 1998-04-10 乳铁蛋白在治疗过敏原诱发疾病中的应用

Country Status (12)

Country Link
US (1) US20030190303A1 (enExample)
EP (1) EP0979099B1 (enExample)
JP (1) JP2001519815A (enExample)
CN (1) CN1262625A (enExample)
AT (1) ATE297755T1 (enExample)
AU (1) AU747385C (enExample)
CA (1) CA2285960A1 (enExample)
DE (1) DE69830582T2 (enExample)
ES (1) ES2245028T3 (enExample)
IL (1) IL132293A0 (enExample)
NZ (1) NZ500712A (enExample)
WO (1) WO1998044940A1 (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100467059C (zh) * 2002-05-10 2009-03-11 阿根尼克斯有限公司 乳铁蛋白在治疗恶性肿瘤疾病中的用途
CN102370964A (zh) * 2010-08-16 2012-03-14 李兴德 白细胞介素受体拮抗蛋白在制备皮肤外用制剂中的应用
CN103002907A (zh) * 2010-04-23 2013-03-27 普若拜特有限公司 湿疹治疗
CN112074291A (zh) * 2018-02-07 2020-12-11 耐伊洛斯有限责任公司 预防和治疗呼吸道疾病的组合物
CN114867368A (zh) * 2019-12-11 2022-08-05 N·V·努特里奇亚 用于提高免疫适宜的营养组合物

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050076A1 (en) * 1997-05-03 1998-11-12 Board Of Regents, The University Of Texas System Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
CN100384472C (zh) * 2000-01-14 2008-04-30 明治乳业株式会社 抗原特异性IgE抗体产生抑制剂
RU2165769C1 (ru) * 2000-07-13 2001-04-27 Якубовская Раиса Ивановна Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения
DK2270052T3 (en) 2001-06-26 2018-07-02 Amgen Inc Antibodies to OPGL
JP3668241B2 (ja) * 2001-12-28 2005-07-06 株式会社Ｎｒｌファーマ 脂質代謝改善用組成物
JP3806427B2 (ja) * 2002-01-21 2006-08-09 株式会社Ｎｒｌファーマ 新規鎮痛剤
WO2003099207A2 (en) 2002-05-24 2003-12-04 Agennix Incorporated Oral lactoferrin in the treatment of respiratory disorders
NZ566539A (en) 2002-09-06 2010-01-29 Medarex Inc Therapeutic human anti-IL-1R1 monoclonal antibody
DE60335997D1 (de) * 2002-09-16 2011-03-24 Agennix Inc Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus
US20040152624A1 (en) * 2002-12-06 2004-08-05 Atul Varadhachary Oral lactoferrin in the treatment of sepsis
US7592306B2 (en) 2002-12-10 2009-09-22 Agennix, Inc. Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US8105615B2 (en) * 2003-06-06 2012-01-31 Agennix Incorporated Lactoferrin as an adjuvant in cancer vaccines
US20050075277A1 (en) * 2003-07-10 2005-04-07 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects
US20090203586A1 (en) * 2004-06-11 2009-08-13 Syngenta Limited Method for ameliorating an inflammatory skin condition
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
WO2006098625A1 (en) 2005-03-15 2006-09-21 Campina Nederland Holding B.V. Dermatologic use of milk proteins
US8178486B2 (en) * 2005-07-21 2012-05-15 Animal Technology Institute Taiwan Method for promoting hair growth
AU2006300009A1 (en) * 2005-10-14 2007-04-19 Auckland Uniservices Limited Use of lactoferrin fragments and hydrolysates
EP1952818A4 (en) * 2005-10-27 2009-10-21 Sunstar Inc OSTEOCLASTICIZATION PREPARATION, ORAL AGGREGATION AND PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST BONE DISEASES WITH LACTOFERRIN-CONTAINING LIPOSOME
WO2020035482A1 (en) 2018-08-13 2020-02-20 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
WO2023222565A1 (en) 2022-05-16 2023-11-23 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation
CN115737787B (zh) * 2022-12-15 2024-04-19 四川大学 乳铁蛋白联合胆碱在制备预防和/或治疗阿尔兹海默症的药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641696B2 (fr) * 1986-04-11 1991-03-08 Sederma Sa Utilisation d'un melange renfermant de la lactoferrine dans des preparations cosmetiques anti-radicaux libres
FR2596986B1 (fr) * 1986-04-11 1988-09-23 Sederma Sa Utilisation de la lactoferrine dans des preparations cosmetiques, antiradicaux libres
FR2685202B1 (fr) * 1991-12-24 1995-03-24 Sederma Sa Nouvelle methode de traitement pharmaceutique et cosmetique pour la regulation de la seborrhee, de l'acne et de la flore cutanee.
JP3184923B2 (ja) * 1992-01-08 2001-07-09 ビオ セレ ラボラトワール エス ア 抗リウマチ剤
JPH05279266A (ja) * 1992-04-02 1993-10-26 Imuno Japan:Kk 歯周病の治療・予防用医薬組成物
JP3163171B2 (ja) * 1992-07-15 2001-05-08 森永乳業株式会社 ＩｇＡ産生促進剤
JP3746081B2 (ja) * 1994-02-24 2006-02-15 森永乳業株式会社 動物皮膚病治療剤
JPH0859450A (ja) * 1994-08-18 1996-03-05 Kose Corp 皮膚外用剤
JP2832517B2 (ja) * 1994-12-09 1998-12-09 雪印乳業株式会社 大腸菌付着阻止剤
JP3911642B2 (ja) * 1995-06-06 2007-05-09 株式会社加美乃素本舗 皮膚外用剤
JP3888707B2 (ja) * 1996-01-22 2007-03-07 森永乳業株式会社 血管新生病治療剤
US6111081A (en) * 1996-05-31 2000-08-29 Baylor College Of Medicine Lactoferrin variants and uses thereof

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100467059C (zh) * 2002-05-10 2009-03-11 阿根尼克斯有限公司 乳铁蛋白在治疗恶性肿瘤疾病中的用途
CN100467060C (zh) * 2002-05-10 2009-03-11 阿根尼克斯有限公司 通过瘤内施用乳铁蛋白治疗恶性肿瘤疾病的用途
CN103002907A (zh) * 2010-04-23 2013-03-27 普若拜特有限公司 湿疹治疗
CN102370964A (zh) * 2010-08-16 2012-03-14 李兴德 白细胞介素受体拮抗蛋白在制备皮肤外用制剂中的应用
CN102370964B (zh) * 2010-08-16 2015-12-09 李兴德 白细胞介素受体拮抗蛋白在制备皮肤外用制剂中的应用
CN112074291A (zh) * 2018-02-07 2020-12-11 耐伊洛斯有限责任公司 预防和治疗呼吸道疾病的组合物
CN114867368A (zh) * 2019-12-11 2022-08-05 N·V·努特里奇亚 用于提高免疫适宜的营养组合物

Also Published As

Publication number Publication date
AU747385B2 (en) 2002-05-16
EP0979099A1 (en) 2000-02-16
IL132293A0 (en) 2001-03-19
WO1998044940A1 (en) 1998-10-15
DE69830582T2 (de) 2006-05-04
AU747385C (en) 2003-01-30
ATE297755T1 (de) 2005-07-15
ES2245028T3 (es) 2005-12-16
NZ500712A (en) 2002-10-25
CA2285960A1 (en) 1998-10-15
JP2001519815A (ja) 2001-10-23
DE69830582D1 (de) 2005-07-21
US20030190303A1 (en) 2003-10-09
EP0979099B1 (en) 2005-06-15
AU6964798A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
CN1262625A (zh) 乳铁蛋白在治疗过敏原诱发疾病中的应用
Angeletti et al. Healing rituals and sacred serpents
KR101954869B1 (ko) 탈모증 치료제
EP2992881B1 (en) Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator t cells and promoting proliferation of regulator t cells
JP6266811B2 (ja) 血管新生病の免疫療法
AU2012311483B2 (en) Combination therapy using immunoglobulin and C1-inhibitor
CN1188164C (zh) 调节吞噬作用和icam－1表达的组合物和方法
US7666842B2 (en) Elastin peptide analogs and uses thereof
US20020025316A1 (en) Pharmaceutical composition containing inhibitors of interferon-gamma
JP2008501772A (ja) 炎症性皮膚状態を寛解するための方法
CN119548617A (zh) 重组xvii型人源化胶原蛋白的新用途
CN1418105A (zh) Mia在免疫疗法中的应用
CN1278184A (zh) 预防或治疗局部缺血性疾病的药剂
JPH11511160A (ja) インターフェロン−ガンマインヒビター含有医薬組成物
WO1999064066A1 (fr) Agents induisant une tolerance immunitaire et contenant de la keratine dure ou une substance ressemblant a la keratine
JPWO2018084311A1 (ja) 炎症性皮膚疾患の予防又は治療剤
JP2003534237A (ja) 食欲の抑制又は満腹の惹起のための成長ホルモン又は成長ホルモン分泌促進物質の使用
MXPA99009240A (en) Use of lactoferin in the treatment of allergen induced disorders
US20210177798A1 (en) NON-STEROIDAL SELECTIVE GLUCOCORTICOID RECEPTOR AGONISTIC MODULATORS (SEGRAMs) AND USES THEREOF
RU2586286C2 (ru) Применение для лечения и профилактики атеросклероза белково-пептидного комплекса (далее-бпк), полученного из эмбриональной нервной ткани или из быстрозамороженного эмбрионального мозга сельскохозяйственных копытных животных, влияющего на обратный транспорт холестерина из сосудистой стенки и профиль активации моноцитов у пациентов с выраженным атеросклерозом магистральных сосудов или с предрасположенностью к сердечно-сосудистым заболеваниям и способ профилактики и лечения пациентов с атеросклерозом артериальных сосудов и с заболеваниями, вызванными атеросклерозом магистральных и периферических сосудов головного мозга, сердца, сосудов нижних конечностей и аорты (два варианта)
US20040208871A1 (en) Pharmaceutical composition containing inhibitors of interferon-gamma
JPH01279840A (ja) 新規外用組成物
WO2021112235A1 (ja) Ｃ３腎症を予防又は治療するための医薬、医薬組成物及び補体Ｃ３ｂ分解促進剤
WO2021187944A1 (ko) 코엔자임 q10 가용화 조성물의 치료학적 용도
HK1033091A (en) Compositions and methods for regulating phagocytosis and icam-1 expression

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication